PD-L1 (Atezolizumab biosimilar) Antibody from ICHORBIO

Search, find, compare suppliers for anti-PD-L1 (Atezolizumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityPD-L1 (Atezolizumab biosimilar)
Clonemonoclonal
Host SpeciesHumanized
Reactive Specieshuman
IsotypeIgG1 kappa
FormatProtein A/G purified, low endotoxin
Size5mg
Concentration1.0 - 5.0 mg/ml
ApplicationsRUO
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionSpecificity: detects human PDL-1. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Atezolizumab. Atezolizumab biosimilar is an Fc-engineered, humanized, monoclonal antibody that binds to PD-L1 and blocks interactions with the PD-1 and B7.1 receptors. Atezolizumab biosimilar is a non-glycosylated IgG1 kappa immunoglobulin that has a calculated molecular mass of 145 kDa.
Immunogenn/a
Other NamesProgrammed cell death 1 ligand 1, Cd274, PDCD1 ligand 1, Programmed death ligand 1, B7 homolog 1, B7-H1, B7h1, Pdcd1l1, Pdcd1lg1, Pdl1, PDL-1
Gene, Accession #UniProt: Q9NZQ7
Catalog #ICH4018-5mg
Price$718
Order / More InfoPD-L1 (Atezolizumab biosimilar) Antibody from ICHORBIO
Product Specific Referencesn/a
ICHORBIO
ICHORBIO
ICHORBIO
Boston House, Grove Business Park
Downsview Road
Wantage OX12 9FF ENGLAND

orders@ichor.bio

https://ichor.bio

U.S. OFFICE
987 Old Eagle School Rd, Ste 709
Wayne, PA 19087
us@ichor.bio


Profile of ICHORBIO
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.